Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CeriBell, Inc. (CBLL : NSDQ)

• Company Description    CeriBell Inc. is a commercial-stage medical technology company. It focused on transforming the diagnosis and management of patients with serious neurological conditions. The company is an AI-powered, rapidly deployable point-of-care electroencephalography platform designed to address the unmet needs of patients in the acute care setting. CeriBell Inc. is based in Sunnyvale, Calif. Number of Employees: 327

• Price / Volume Information    Yesterday's Closing Price: $16.91 Daily Weekly Monthly 20 Day Moving Average: 382,702 shares Shares Outstanding: 37.94 (millions) Market Capitalization: $641.62 (millions) Beta: 0.77 52 Week High: $24.33 52 Week Low: $10.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -14.29% -14.92% 12 Week -16.12% -18.42% Year To Date -22.89% -31.40%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 360 N. PASTORIA AVENUE - SUNNYVALE,CA 94085 USA ph: 800-436-0826 fax: - investors@ceribell.com https://ceribell.com

• General Corporate Information    Officers Xingjuan (Jane) Chao - President; Chief Executive Officer; and Director Rebecca Robertson - Chair of the Board of Directors Scott Blumberg - Chief Financial Officer David Foehr - Senior Vice President; Finance Juliet Tammenoms Bakker - Director Peer Information CeriBell, Inc. (BJCT) CeriBell, Inc. (CADMQ) CeriBell, Inc. (APNO) CeriBell, Inc. (UPDC) CeriBell, Inc. (IMTIQ) CeriBell, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 15678C102 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/10/26 Share - Related Items Shares Outstanding: 37.94 Most Recent Split Date: (:1) Beta: 0.77 Market Capitalization: $641.62 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.38 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.69 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 25.90% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.55 Price/Cash Flow: - Price / Sales: 6.75 EPS Growth vs. Year Ago Period: -44.44% vs. Previous Quarter: -44.44% Sales Growth vs. Year Ago Period: 29.30% vs. Previous Quarter: 6.90% ROE 06/30/26 - - 03/31/26 - -38.19 12/31/25 - -31.77 ROA 06/30/26 - - 03/31/26 - -30.92 12/31/25 - -26.17 Current Ratio 06/30/26 - - 03/31/26 - 10.44 12/31/25 - 9.73 Quick Ratio 06/30/26 - - 03/31/26 - 10.01 12/31/25 - 9.35 Operating Margin 06/30/26 - - 03/31/26 - -63.51 12/31/25 - -59.97 Net Margin 06/30/26 - - 03/31/26 - -63.51 12/31/25 - -59.97 Pre-Tax Margin 06/30/26 - - 03/31/26 - -63.51 12/31/25 - -59.97 Book Value 06/30/26 - - 03/31/26 - 3.72 12/31/25 - 4.19 Inventory Turnover 06/30/26 - - 03/31/26 - 1.78 12/31/25 - 1.67 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.14 12/31/25 - 0.13 Debt-to-Capital 06/30/26 - - 03/31/26 - 12.39 12/31/25 - 11.31

Powered by Zacks Investment Research ©